LABCORP HOLDINGS INC.·4

Feb 13, 12:58 PM ET

Wengel Kathryn E 4

Research Summary

AI-generated summary

Updated

Labcorp (LH) Director Kathryn E. Wengel Receives 897 Shares

What Happened

  • Kathryn E. Wengel, a director of Labcorp Holdings Inc. (LH), had 897 restricted stock units (RSUs) vest and convert into 897 shares on February 11, 2026. The Form 4 records an acquisition (conversion/exercise, code M) of 897 shares and a contemporaneous disposition of 897 shares reported at $0.00 (total $0).

Key Details

  • Transaction date: 2026-02-11 (reported on Form 4 filed 2026-02-13 — timely filing).
  • Acquired: 897 shares via conversion/exercise of RSUs (transaction code M); price listed as N/A for acquisition.
  • Disposed: 897 shares at $0.00 (total $0) — reported as a derivative disposition.
  • Footnotes: F1 — Each RSU represents the right to one share. F2 — RSUs vested fully on Feb 11, 2026. F3 — The number shown reflects the aggregate RSUs held by the reporting person (as disclosed).
  • Shares owned after transaction: Not specified in the provided filing excerpt.

Context

  • This was not an open‑market buy or sale; it reflects RSUs vesting and conversion to stock. A $0.00 disposition on a Form 4 often indicates shares were withheld or retained to satisfy tax withholding or similar employer obligations, though the filing excerpt does not explicitly state the reason.
  • The activity is routine compensation-related insider reporting rather than a market purchase or sale that would more directly signal a trading view.